Concept Life Sciences has one of the largest chemistry groups in the UK working from state-of-the-art facilities and offering a comprehensive medicinal chemistry service to our clients.
Concept provides medicinal chemistry as a standalone or part of a fully integrated service which includes DMPK (in vitro, in vivo), biosciences, toxicology, API manufacture and solid state analysis. We have recognised therapeutic area expertise in areas such as immuno-oncology, neurodegeneration/regeneration, immunology and inflammation.
Over 85% of our chemists are educated to PhD level and have diverse industry experience drawn from a wide range of major pharmaceutical and biotech companies.
Our medicinal chemistry team work closely with our ADMET and in vitro biology screening teams to deliver highly efficient cycle times through the design-make-test cycle. We provide data, scientific insight and interpretation to inform the next cycle of design. We work on projects throughout the drug discovery process offering a range of services:
We understand the importance of delivering against the project progression criteria and work closely with our customers to understand the competitive landscape and drug candidate proposition.
Concept scientists are viewed as true members of our partners’ project teams and we have established long-standing relationships, providing regular reporting on SAR development, LIPE progress, data trends and the evolving pharmacophore/protein docking hypothesis.
In addition, Concept’s medicinal chemists have expertise in several specialist areas: